John E. Tavis

5.2k citations
124 papers · 4.3k · 1 hit paper · h-index 35

Impact in

  • Hepatology top 0.2%
    • Hepatitis C virus research
    • Hepatitis Viruses Studies and Epidemiology
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment
    • Herpesvirus Infections and Treatments

Papers in

    • Hepatitis C virus research 78
    • Hepatitis B Virus Studies 80
    • Liver Disease Diagnosis and Treatment 13
    • Herpesvirus Infections and Treatments 13

John E. Tavis

122 papers receiving 4.2k citations

John E. Tavis's Hit Papers

A global scientific strategy to cure hepatitis B 2019 · 400 citations
4000+2+4Years since publication100200300400

Peers

John E. Tavis
Comparison fields: 5 of 93
  • Hepatology 2.3k
  • Epidemiology 2.8k
  • Virology 361
  • Infectious Diseases 1.1k
  • Animal Science and Zoology 159
Replace Ryosuke Suzuki with:
Ryosuke Suzuki Japan
Susan L. Uprichard United States
Brent E. Korba United States
Gilles Duverlie France
Dieter Glebe Germany
Klaus Klumpp United States
Chao Lin United States
Zijiang Zhao Japan
Artur Kaul Germany
Pablo Gastaminza Spain
John E. Tavis relative to Ryosuke Suzuki Japan Ryosuke Suzuki's profile →
Citations per field
00.5×1.5×
Ryosuke Suzuki · 1×
Citations per year

Countries citing papers authored by John E. Tavis

Since Specialization
Citations

This map shows the geographic impact of John E. Tavis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Tavis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Tavis more than expected).

Fields of papers citing papers by John E. Tavis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Tavis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Tavis. The network helps show where John E. Tavis may publish in the future.

Co-authors

The 25 scholars most cited alongside John E. Tavis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John E. Tavis Line = papers co-authored together John E. Tavis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A global scientific strategy to cure hepatitis B
Hit paper breakdown →
2019400
2 2010202
3 2012192
4 1996161
5 1994157
6 2005149
7 2009111
8 2007105
9 2007100
10 201397
11 199690
12 199689
13 201384
14 199377
15 201476
16 199875
17 201774
18 198968
19 200868
20 202266

About John E. Tavis

John E. Tavis is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Virology and Immunology, having authored 124 papers that have together received 4.3k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (80 papers), Hepatitis C virus research (78 papers), Viral gastroenteritis research and epidemiology (19 papers), HIV/AIDS drug development and treatment (18 papers), Liver Disease Diagnosis and Treatment (13 papers), Herpesvirus Infections and Treatments (13 papers), HIV Research and Treatment (10 papers) and Viral Infections and Outbreaks Research (9 papers). The work is most often cited by research in Hepatology (2.3k citations), Epidemiology (2.8k citations), Virology (361 citations), Infectious Diseases (1.1k citations) and Animal Science and Zoology (159 citations). John E. Tavis has collaborated with scholars based in United States, Spain and China. Frequent co-authors include Feng Cao, Don Ganem, Don Ganem, Elena E. Lomonosova, Ermei Yao, Maureen J. Donlin, Volker Bruss, Silvia Perri, Rajeev Aurora and Xiaohong Cheng. Their work appears in journals such as Journal of Virology, Antiviral Research, Virology, PLoS ONE and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact